olaparib improves disease-free survival in high-risk early-stage her2-negative breast cancer wit...
Published 2 years ago • 289 plays • Length 8:09Download video MP4
Download video MP3
Similar videos
-
2:44
olympia: adjuvant olaparib in gbrcam, her2-negative, high-risk, early breast cancer
-
3:50
olaparib beneficial for brca-mutated her2-negative breast cancer
-
2:58
olympia: adjuvant olaparib following chemo significantly improves idfs
-
1:00
olaparib or abemaciclib high-risk brca positive breast cancer?
-
3:14
parp inhibitor staves off recurrence in early brca-mutant breast cancer - medpage today
-
3:05
exploring the use of olaparib in advanced breast cancer
-
2:35
treatment options for high risk early breast cancer
-
1:08
4-year monarche results: increasing benefits with abemaciclib et for er /her2- high-risk early bc
-
9:17
i-spy 2: durvalumab in combination with olaparib and paclitaxel in high-risk her2 negative stage...
-
5:49
perspectives on the olympia study of adjuvant olaparib in early breast cancer | nadine tung
-
3:50
update from kaitlin for high-risk her2-positive early breast cancer
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer
-
15:46
adjuvant parp inhibitors in patients with high-risk early-stage her2-negative breast cancer and g...
-
5:00
olympia: adjuvant olaparib delays recurrence of brca-mutant breast cancer | judy garber
-
46:31
adjuvant therapy | 2023 best of breast conference
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
3:24
solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer
-
6:16
asco 2021 - highlights on shifting parpi to early breast cancer: the olympia study
-
2:22
cdk4/6 inhibitors in early stage hr /her2- disease